- Report
- September 2025
- 22 Pages
Bolivia
From €995EUR$1,195USD£894GBP
- Report
- April 2025
- 28 Pages
Brazil
From €995EUR$1,195USD£894GBP
- Report
- January 2025
- 24 Pages
Singapore
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 22 Pages
Indonesia
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 22 Pages
North Macedonia
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 20 Pages
Tunisia
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 23 Pages
Kenya
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 21 Pages
Uzbekistan
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 24 Pages
South Africa
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 26 Pages
Ukraine
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 23 Pages
Morocco
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 24 Pages
Ireland
From €995EUR$1,195USD£894GBP
- Report
- October 2024
- 25 Pages
Nigeria
From €995EUR$1,195USD£894GBP
- Report
- September 2024
- 24 Pages
Spain
From €995EUR$1,195USD£894GBP
- Report
- September 2024
- 24 Pages
New Zealand
From €995EUR$1,195USD£894GBP
- Report
- September 2024
- 25 Pages
Thailand
From €995EUR$1,195USD£894GBP
- Report
- September 2024
- 24 Pages
Philippines
From €995EUR$1,195USD£894GBP
- Report
- September 2024
- 28 Pages
China, Hong Kong
From €995EUR$1,195USD£894GBP
- Report
- September 2024
- 20 Pages
Algeria
From €995EUR$1,195USD£894GBP

The Cold Sore Drug market is a subset of the Infectious Diseases Drugs market. Cold Sores, also known as fever blisters, are caused by the herpes simplex virus and are highly contagious. Cold Sore Drugs are used to treat the symptoms of the virus, such as pain, itching, and burning. These drugs can also help reduce the duration of the outbreak and prevent future outbreaks. Commonly used Cold Sore Drugs include antiviral medications, topical creams, and ointments.
The Cold Sore Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include Sanofi, Bayer, and Mylan. Show Less Read more